Bebac user
☆    

Egypt,
2021-12-06 01:36
(1264 d 15:03 ago)

Posting: # 22687
Views: 3,939
 

 FDA: SAS-code for NTIDs [RSABE / ABEL]

Post reply
I am a beginner sas user, could anyone help me how to apply RSABE for NTIs drugs?
And how to calculate variability comparison?

Edit: Subject line changed; see also this post #2. [Helmut]
 
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2021-12-06 11:55
(1264 d 04:44 ago)

@ Bebac user
Posting: # 22688
Views: 3,239
 

 FDA: SAS-code for NTIDs

Post reply
Hi,

the [image] published SAS-code:
  • In the Draft Guidance on Warfarin Sodium (December 2012).
    Later product-specific guidance refer to this one.
  • In APPENDIX C of the Draft Guidance Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Sub­mitted Under an ANDA (August 2021).
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
44 visitors (0 registered, 44 guests [including 22 identified bots]).
Forum time: 17:40 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5